CE Marking & International Expansion
Regulatory & Commercial
RegulatoryActive
Key Facts
About Positron
Positron is a long-established leader in cardiac PET imaging, with over 40 years of experience in nuclear medicine. The company has evolved from a PET-focused firm to a developer of integrated PET-CT systems, such as the NeuSight 64-slice scanner, targeting the specific needs of cardiology practices. Its business model combines technology sales with unique financial offerings like rental and lease-to-own programs to enhance accessibility. Positron is now expanding its focus to include oncology imaging and pursuing regulatory approvals to enter international markets in Europe and Canada.
View full company profileTherapeutic Areas
Other Regulatory & Commercial Drugs
| Drug | Company | Phase |
|---|---|---|
| European Market Expansion | UroViu | Commercial |